fluorexon has been researched along with Lung Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Genshaft, AS; Huang, S; Jacks, T; Jaeger, AM; King, RP; Mana, MD; Mead, BE; Mitsialis, V; Navia, AW; Shalek, AK; Snapper, SB; Tzouanas, CN; Van Humbeck, JF; Yilmaz, ÖH; Ziegler, CGK | 1 |
| Dauguet, N; Hérin, C; Huaux, F; Ibouraadaten, S; Loira-Pastoriza, C; Tyteca, D; Ucakar, B; Vanbever, R; Vanvarenberg, K | 1 |
| Adeyeye, MC; Gibbs, JP; Shen, DD; Yang, Z | 1 |
| Cho, HA; Kim, IY; Kim, JS; Kim, MJ; Lee, HJ; Lee, IA; Lim, SK | 1 |
| Broxterman, HJ; Dingemans, AM; Flens, MJ; Gazdar, AF; Giaccone, G; Pinedo, HM; Rubio, GJ; Scheper, RJ; van Ark-Otte, J | 1 |
| Fukuda, M; Kawabata, S; Kohno, S; Nakamura, T; Nakano, R; Noguchi, Y; Oka, M; Soda, H; Terashi, K; Tsukamoto, K | 1 |
| Allain, N; Anger, JP; Courtois, A; Fardel, O; Guillouzo, A; Payen, L; Vernhet, L | 1 |
| Courtois, A; Delugin, L; Fardel, O; Guillouzo, A; Payen, L; Trinquart, Y | 1 |
| Courtois, A; de Vries, EG; Fardel, O; Guillouzo, A; Payen, L; Vernhet, L | 1 |
9 other study(ies) available for fluorexon and Lung Neoplasms
| Article | Year |
|---|---|
Live cell tagging tracking and isolation for spatial transcriptomics using photoactivatable cell dyes.
Topics: Animals; Biological Assay; Cell Tracking; Coloring Agents; Cytokines; Female; Fluoresceins; Fluorescent Dyes; Health Status; HEK293 Cells; Humans; Lung Neoplasms; Male; Mice; Myeloid Cells; Organoids; Phenotype; Stem Cells; Transcriptome; Tumor Microenvironment; Ultraviolet Rays | 2021 |
Cationic Nanoliposomes Are Efficiently Taken up by Alveolar Macrophages but Have Little Access to Dendritic Cells and Interstitial Macrophages in the Normal and CpG-Stimulated Lungs.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adjuvants, Immunologic; Animals; Cancer Vaccines; Cell Line, Tumor; Cell Survival; Cholesterol; CpG Islands; Dendritic Cells; Drug Delivery Systems; Fatty Acids, Monounsaturated; Female; Fluoresceins; Fluorescent Dyes; gp100 Melanoma Antigen; Lipopeptides; Liposomes; Lung; Lung Neoplasms; Macrophages, Alveolar; MART-1 Antigen; Mice; Nanoparticles; Quaternary Ammonium Compounds; Tissue Distribution | 2019 |
Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.
Topics: Adenocarcinoma; Animals; Biological Transport, Active; Brain; Cattle; Cells, Cultured; Cyclooxygenase Inhibitors; Dinitrophenols; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Fluoresceins; GABA Agents; Humans; Indomethacin; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Pancreatic Neoplasms; Probenecid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rotenone; Temperature; Tritium; Uncoupling Agents; Uricosuric Agents; Valproic Acid | 2004 |
Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cell Survival; Chemistry, Pharmaceutical; Deoxycytidine; Dose-Response Relationship, Drug; Drug Compounding; ErbB Receptors; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Gemcitabine; Humans; Hydrogen-Ion Concentration; Lipids; Liposomes; Lung Neoplasms; Particle Size; Tumor Stem Cell Assay | 2008 |
MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Biological Transport; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; DNA, Complementary; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluoresceins; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Tumor Cells, Cultured | 1996 |
A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein.
Topics: Adenocarcinoma; ATP-Binding Cassette Transporters; Carcinoma, Squamous Cell; Chromones; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Leukotriene Antagonists; Leukotriene C4; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured; Vincristine | 1998 |
Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells.
Topics: Antimony; Antineoplastic Agents; Arsenites; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Cadmium Chloride; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Gene Amplification; Humans; Inhibitory Concentration 50; Lung Neoplasms; Meglumine; Metallothionein; Metals, Heavy; Multidrug Resistance-Associated Proteins; Propionates; Quinolines; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation; Zinc Sulfate | 1999 |
Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486.
Topics: ATP-Binding Cassette Transporters; Dexamethasone; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Estradiol; Fluoresceins; Hormone Antagonists; Humans; Lung Neoplasms; Mifepristone; Multidrug Resistance-Associated Proteins; Progesterone; Tumor Cells, Cultured | 1999 |
Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells.
Topics: Antibiotics, Antitubercular; ATP-Binding Cassette Transporters; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Fluoresceins; Humans; Lung Neoplasms; Models, Chemical; Multidrug Resistance-Associated Proteins; Rifampin; Rifamycins; Tumor Cells, Cultured | 1999 |